Enrolling by Invitation
Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection
NCT04762459
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Chinese Academy of Medical Science Beijing, Beijing Municipality, China
- Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
- Peking Union Medical College Hospital Beijing, China
- Hunan Cancer Hospital Changsha, China